QNTM

MGNI

Comm Servicesmid cap
QNTM SCORE
58/100
MODERATE CONVICTION
top 13% of the universe

As of 2026-09-10, MGNI scores 58out of 100 on QNTM’s five-factor quantitative model, a moderate conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. MGNI trades at $23.55, within its fair-value band.

MGNI scores 58 out of 100 on QNTM's five-factor model — a moderate reading — neither strongly favored nor flagged for weakness at 58. Its strongest factor is momentum at 81 (exceptional), where price trend and relative strength are working in its favor, followed by value at 77. The weakest is volume at 38, where volume gives little confirmation. Among Comm Services stocks it ranks in roughly the top 13% of the Comm Services names the model scores.

On valuation, MGNI is priced near the top of its recent range — the rich end on the model's valuation read. The blended composite before the macro overlay was 63. Same-sector names the model rates nearby include MTCH, TIGO, NIQ.

This is a descriptive factor read on MGNI, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where MGNI sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

Momentum81
Quality51
Value77
Volume38
Sentiment41

VALUATION RANGE

QNTM’s descriptive fair-value band for MGNI runs $13.71–$24.51. Current price $23.55 sits within its fair-value band. This is valuation context, not a price target.

MGNI APPEARS IN

Top Momentum
See MGNI update live, and set an alert when its conviction changes

QNTM rescores MGNI and ~1,400 other names every session. Track it, get notified the moment it crosses a conviction tier, and see the full signal history.

Start free →

OTHER COMM SERVICES NAMES

MTCH62TIGO62NIQ59MSGE57VZ55TDS55OMC54CARG54

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-10.